David Laurent Niquille
About David Laurent Niquille
David Laurent Niquille is a scientist specializing in biochemistry and synthetic biology. He currently works at Mythic Therapeutics, Inc. and has a strong academic background, including degrees from ETH Zürich and research experience at MIT.
Work at Mythic Therapeutics
David Laurent Niquille has been employed at Mythic Therapeutics, Inc. as a Scientist since 2021. His role is based in Waltham, Massachusetts. At Mythic Therapeutics, he contributes to the development of innovative therapeutic solutions, focusing on the application of his expertise in biochemistry and synthetic biology.
Education and Expertise
David Niquille holds a Bachelor of Science in Biochemistry from ETH Zürich, completed between 2007 and 2010. He further advanced his education with a Master of Science and a Doctor of Sciences in Biological Chemistry from the same institution, graduating in 2012 and 2017, respectively. Additionally, he is currently studying Synthetic Biology at the Massachusetts Institute of Technology as a Postdoctoral Associate since 2018.
Background
David Niquille has an extensive educational background that includes an Erasmus Exchange Semester at KTH Royal Institute of Technology in 2009 and a Research Project in Protein Engineering at EPFL (École polytechnique fédérale de Lausanne) in 2010. His diverse experiences have contributed to his comprehensive understanding of biochemical research and applications.
Previous Experience at MIT
Before joining Mythic Therapeutics, David Niquille worked as a Postdoctoral Research Fellow at the Massachusetts Institute of Technology from 2018 to 2021. During this period, he engaged in advanced research, further enhancing his expertise in the field of biochemistry and synthetic biology.
Research Contributions
David Niquille has published work focusing on the therapeutic applications and prospects of biparatopic antibodies. He co-authored a journal article on this topic with colleagues Kyle Fitzgerald and Nimish Gera, contributing to the scientific community's understanding of antibody applications in therapy.